These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 9349746

  • 21. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C, Lobaccaro JM, Lumbroso S, Lechevallier E, Mottet N, Gibelin B, Sultan C.
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [Abstract] [Full Text] [Related]

  • 22. [Flutamide, an alternative for patients with benign prostatic hyperplasia (BPH) that cannot be treated with surgery].
    Granados EA.
    Arch Esp Urol; 1998 Sep; 51(7):675-9. PubMed ID: 9807893
    [Abstract] [Full Text] [Related]

  • 23. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
    Span PN, Völler MC, Smals AG, Sweep FG, Schalken JA, Feneley MR, Kirby RS.
    J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.
    Anwarul Islam AK, Kashem MA, Shameem IA, Kibria SA.
    Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):54-61. PubMed ID: 16967810
    [Abstract] [Full Text] [Related]

  • 25. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M, Bartsch W, Thomsen M, Voigt KD.
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [Abstract] [Full Text] [Related]

  • 26. Long-term effects of finasteride on prostate tissue composition.
    Marks LS, Partin AW, Dorey FJ, Gormley GJ, Epstein JI, Garris JB, Macairan ML, Shery ED, Santos PB, Stoner E, deKernion JB.
    Urology; 1999 Mar; 53(3):574-80. PubMed ID: 10096387
    [Abstract] [Full Text] [Related]

  • 27. Effects of two different medical treatments on dihydrotestosterone content and androgen receptors in human benign prostatic hyperplasia.
    Petrangeli E, Sciarra F, Di Silverio F, Toscano V, Lubrano C, Conti C, Concolino G.
    J Steroid Biochem; 1988 Mar; 30(1-6):395-9. PubMed ID: 2455099
    [Abstract] [Full Text] [Related]

  • 28. Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia.
    Stone NN, Clejan SJ.
    J Androl; 1991 Mar; 12(6):376-80. PubMed ID: 1722793
    [Abstract] [Full Text] [Related]

  • 29. [Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume].
    Granados Loarca EA.
    Arch Esp Urol; 1999 Apr; 52(3):201-8. PubMed ID: 10371735
    [Abstract] [Full Text] [Related]

  • 30. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
    Lucia MS, Sporn MB, Roberts AB, Stewart LV, Danielpour D.
    J Cell Physiol; 1998 May; 175(2):184-92. PubMed ID: 9525477
    [Abstract] [Full Text] [Related]

  • 31. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
    Zhao XF, Yang Y, Wang W, Qiu Z, Zhang P, Wang B.
    Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
    [Abstract] [Full Text] [Related]

  • 32. Growth factor expression in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens.
    Pollan MC, Benghuzzi HA, Tucci M.
    Biomed Sci Instrum; 2003 Feb; 39():329-34. PubMed ID: 12724915
    [Abstract] [Full Text] [Related]

  • 33. Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia.
    Memis A, Ozden C, Ozdal OL, Guzel O, Han O, Seckin S.
    Urol Int; 2008 Feb; 80(2):177-80. PubMed ID: 18362489
    [Abstract] [Full Text] [Related]

  • 34. Clinical and biological characteristics of familial benign prostatic hyperplasia.
    Sanda MG, Doehring CB, Binkowitz B, Beaty TH, Partin AW, Hale E, Stoner E, Walsh PC.
    J Urol; 1997 Mar; 157(3):876-9. PubMed ID: 9072590
    [Abstract] [Full Text] [Related]

  • 35. Continuous finasteride therapy for benign prostate hypertrophy upgrades both neuroendorcine differentiation and aggressive prostate cancer.
    Tarle M, Spajic B, Kraljic I, Kusic Z.
    Anticancer Res; 2009 May; 29(5):1797-801. PubMed ID: 19443407
    [Abstract] [Full Text] [Related]

  • 36. Comparative analysis of prostatic acid phosphatase and prostate-specific antigen mRNA levels in hyperplastic prostate stimulated with steroid hormones and growth factors.
    Dulińska J, Laidler P, Labedź M.
    Acta Biochim Pol; 2002 May; 49(2):357-68. PubMed ID: 12362977
    [Abstract] [Full Text] [Related]

  • 37. Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer.
    Hsieh JT, Chen SC, Yu HJ, Chang HC.
    Prostate; 2011 Jul; 71(10):1115-21. PubMed ID: 21557276
    [Abstract] [Full Text] [Related]

  • 38. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
    Sciarra F.
    Ann N Y Acad Sci; 1995 Jun 12; 761():66-78. PubMed ID: 7542859
    [Abstract] [Full Text] [Related]

  • 39. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
    Marks LS, Hess DL, Dorey FJ, Luz Macairan M, Cruz Santos PB, Tyler VE.
    Urology; 2001 May 12; 57(5):999-1005. PubMed ID: 11337315
    [Abstract] [Full Text] [Related]

  • 40. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.
    Keetch DW, Andriole GL, Ratliff TL, Catalona WJ.
    Urology; 1997 Dec 12; 50(6):901-5. PubMed ID: 9426721
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.